Inoviq Share Price and Company Fundamentals
Last traded: Today at 1:12 AM
INOVIQ Ltd engages in the research, development, and commercialization of diagnostic products for the early detection of cancer to enhance patient outcomes in Australia. The company offers hTERT test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for ovarian and breast cancers, and research-stage projects for prostate and other cancers. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.
|Primary activities||Developing and commercialising cancer diagnostic products.|
|Industry / Sector||Diagnostics & Research / Healthcare|
|Full time employees||15|
|Mailing address||23 Normanby Road Notting Hill VIC 3168 Australia|
|Phone / Fax||61 3 9548 7586 /|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Inoviq does not pay dividends.
As of Jan 2022, following are the company executives and directors listed on Inoviq.
|Dr. Leearne Maree Hinch B.Sc., B.V.M.S., BSc., M.B.A., M.R.C.V.S.||Chief Exec. Officer||396.22k|
|Mr. Tony Di Pietro AGIA, B.Com, C.A., CPA, M.A.I.C.D.||CFO & Company Sec.||285.74k|
|Mr. Peter Lynton Gunzburg ASIA, B Comm, B.Com.||Managing Director||69||6.84k|
|Prof. Gregory Edward Rice BSc (Hons), GradDipMgt, MHA, Ph.D.||Chief Scientific Officer|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Inoviq is and its enterprise value is .
Companies similar to Inoviq (IIQ)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Inoviq (ASX:IIQ) Frequently Asked Questions
1. What is Inoviq's Stock Symbol?
Inoviq trades on ASX under the ticker symbol "IIQ".
2. What is Inoviq's stock price today?
One share of IIQ stock can currently be purchased for approximately $1.1.
3. How can I contact Inoviq?
Inoviq's mailing address is 23 Normanby Road Notting Hill VIC 3168 Australia. The company can be reached via phone at 61 3 9548 7586.
4. What is Inoviq's official website?
The official website of Inoviq is https://www.bard1.com.
5. Which share registry manages Inoviq's stock?
Inoviq's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.